Ngā hua rapu - Curt D. Furberg
- E whakaatu ana i te 1 - 20 hua o te 73
- Haere ki te Whārangi Whai Ake
-
1
Natural Statins and Stroke Risk mā Curt D. Furberg
I whakaputaina 1999Carta -
2
Withdrawal of cerivastatin from the world market mā Curt D. Furberg, Bertram Pitt
I whakaputaina 2001Artigo -
3
-
4
The Record on Rosiglitazone and the Risk of Myocardial Infarction mā Bruce M. Psaty, Curt D. Furberg
I whakaputaina 2007Carta -
5
Rosiglitazone and Cardiovascular Risk mā Bruce M. Psaty, Curt D. Furberg
I whakaputaina 2007Carta -
6
-
7
Thiazolidinediones and Heart Failure mā Sonal Singh, Yoon K. Loke, Curt D. Furberg
I whakaputaina 2007Revisão -
8
-
9
-
10
-
11
-
12
-
13
Parecoxib, Valdecoxib, and Cardiovascular Risk mā Curt D. Furberg, Bruce M. Psaty, Garret A. FitzGerald
I whakaputaina 2005Editorial -
14
Mortality associated with tiotropium mist inhaler in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis of randomised controlled trials mā Sonal Singh, Y. K. Loke, Paul Enright, Curt D. Furberg
I whakaputaina 2011Revisão -
15
Pro-arrhythmic and pro-ischaemic effects of inhaled anticholinergic medications mā Sonal Singh, Yoon K. Loke, Paul Enright, Curt D. Furberg
I whakaputaina 2012Revisão -
16
-
17
-
18
-
19
Surgical bleeding: unexpected effect of a calcium antagonist mā Lynne E. Wagenknecht, Curt D. Furberg, John W. Hammon, Claudine Legault, B. Todd Troost
I whakaputaina 1995Artigo -
20
Ngā utauta rapu:
Ngā marau whai pānga
Medicine
Internal medicine
Cardiology
Confidence interval
Endocrinology
Cholesterol
Intensive care medicine
Pathology
Randomized controlled trial
Alternative medicine
Clinical trial
Diabetes mellitus
Myocardial infarction
Placebo
Disease
Meta-analysis
Physics
Hazard ratio
Incidence (geometry)
Optics
Relative risk
Adverse effect
Blood pressure
Heart failure
Pravastatin
Statin
Anesthesia
Angiotensin-converting enzyme
Coronary heart disease
Engineering